First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 50
- −25 vs. Q4 2023
- Portfolio value
- $1.31B
- +$63.1M (+5.1%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,690,177 | $79.1M | 6.1% | −297,595−15.0% | Reduced | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 5,418,631 | $74.7M | 5.7% | −558,220−9.3% | Reduced | History |
| NTRANatera, Inc. | COM | 656,708 | $60.1M | 4.6% | +490,822+295.9% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,320,172 | $56.8M | 4.4% | −325,318−19.8% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 3,534,993 | $52.7M | 4.0% | −56,783−1.6% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 711,682 | $52.6M | 4.0% | −42,635−5.7% | Reduced | History |
| SWAVShockwave Medical, Inc. | COM | 161,484 | $52.6M | 4.0% | +41,861+35.0% | Added | History |
| NEONeogenomics Inc | COM NEW | 3,302,165 | $51.9M | 4.0% | −624,591−15.9% | Reduced | History |
| IRTCiRhythm Holdings, Inc. | COM | 420,892 | $48.8M | 3.7% | +268,829+176.8% | Added | History |
| FNAParagon 28, Inc. | COM | 3,802,968 | $47.0M | 3.6% | −14,826−0.4% | Reduced | History |
| TCMDTactile Systems Technology Inc | COM | 2,641,975 | $42.9M | 3.3% | −217,979−7.6% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 1,382,860 | $42.1M | 3.2% | +33,417+2.5% | Added | History |
| SIBNSI-BONE, Inc. | COM | 2,473,165 | $40.5M | 3.1% | −74,227−2.9% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 790,446 | $36.9M | 2.8% | +45,781+6.1% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,002,045 | $33.9M | 2.6% | +3,002,045 | New | History |
| RCMR1 RCM Inc. | COM | 2,552,325 | $32.9M | 2.5% | +1,736,346+212.8% | Added | History |
| OSCROscar Health, Inc. | CL A | 2,102,554 | $31.3M | 2.4% | +1,134,919+117.3% | Added | History |
| PHLTPerformant Healthcare Inc | COM | 10,515,127 | $30.9M | 2.4% | +845,017+8.7% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 139,951 | $30.1M | 2.3% | +51,428+58.1% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,193,051 | $29.7M | 2.3% | −357,420−23.1% | Reduced | History |
| STVNStevanato Group S.p.A. | ORD SHS | 835,985 | $26.8M | 2.1% | +106,024+14.5% | Added | History |
| PODDInsulet Corp | Stock | 151,264 | $25.9M | 2.0% | +151,264 | New | History |
| MODNModel N, Inc. | COM | 894,241 | $25.5M | 1.9% | −646,467−42.0% | Reduced | History |
| AVTRAvantor, Inc. | COM | 850,695 | $21.8M | 1.7% | +836,099+5,728.3% | Added | History |
| PRVAPrivia Health Group, Inc. | COM | 1,103,601 | $21.6M | 1.7% | +1,103,601 | New | History |
| ANABAnaptysbio, Inc | COM | 944,110 | $21.3M | 1.6% | −293,068−23.7% | Reduced | History |
| SCTLSocietal CDMO, Inc. | COM | 19,676,396 | $21.3M | 1.6% | 00.0% | Unchanged | History |
| OPRXOptimizeRx Corp | COM NEW | 1,737,584 | $21.1M | 1.6% | +10,286+0.6% | Added | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 501,243 | $19.9M | 1.5% | +501,243 | New | History |
| VERAVera Therapeutics, Inc. | CL A | 436,133 | $18.8M | 1.4% | +436,133 | New | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 475,077 | $16.8M | 1.3% | +114,834+31.9% | Added | History |
| TELATELA Bio, Inc. | COM | 2,754,028 | $15.6M | 1.2% | +199,387+7.8% | Added | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 335,471 | $14.7M | 1.1% | −10,203−3.0% | Reduced | History |
| KRMDKORU Medical Systems, Inc. | COM | 5,220,990 | $12.3M | 0.9% | +57,253+1.1% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 444,953 | $11.0M | 0.8% | −643,848−59.1% | Reduced | History |
| NARIInari Medical, Inc. | Stock | 213,940 | $10.3M | 0.8% | +213,940 | New | History |
| EVHEvolent Health, Inc. | CL A | 288,181 | $9.45M | 0.7% | +206,459+252.6% | Added | History |
| PENPenumbra Inc | COM | 37,955 | $8.47M | 0.6% | +37,955 | New | History |
| THCTenet Healthcare Corp | COM NEW | 79,523 | $8.36M | 0.6% | −115,077−59.1% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 282,766 | $7.67M | 0.6% | −363,291−56.2% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 149,113 | $6.39M | 0.5% | +149,113 | New | History |
| AXGNAxogen, Inc. | COM | 765,886 | $6.18M | 0.5% | +489,397+177.0% | Added | History |
| LIVNLivaNova PLC | SHS | 102,792 | $5.75M | 0.4% | +102,792 | New | History |
| HCATHealth Catalyst, Inc. | COM | 734,681 | $5.53M | 0.4% | −279,794−27.6% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 60,284 | $4.12M | 0.3% | +60,284 | New | History |
| GHGuardant Health, Inc. | COM | 189,765 | $3.91M | 0.3% | +45,716+31.7% | Added | History |
| VTYXVentyx Biosciences, Inc. | COM | 624,842 | $3.44M | 0.3% | +624,842 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 105,948 | $3.01M | 0.2% | +105,948 | New | History |
| SLPSimulations Plus, Inc. | COM | 28,741 | $1.18M | 0.1% | −5,707−16.6% | Reduced | History |
| SONXSonendo, Inc. | COM | 5,143,615 | $544.7K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2023 (37)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| KRTXKaruna Therapeutics, Inc. | COM | 287,037 | $90.9M | 7.3% | History |
| AXNXAxonics, Inc. | COM | 318,668 | $19.8M | 1.6% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 185,579 | $17.9M | 1.4% | History |
| BHVNBiohaven Ltd. | COM | 383,757 | $16.4M | 1.3% | History |
| KIDSOrthopediatrics Corp | COM | 297,509 | $9.67M | 0.8% | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 631,064 | $8.85M | 0.7% | History |
| HALOHalozyme Therapeutics, Inc. | COM | 134,050 | $4.95M | 0.4% | History |
| TECHBIO-TECHNE Corp | COM | 32,339 | $2.50M | 0.2% | History |
| iShares Russell 2000 Growth ETF464287648 | ETF | 5,929 | $1.50M | 0.1% | – |
| EXELExelixis, Inc. | COM | 18,445 | $442.5K | <0.1% | History |
| ELVElevance Health, Inc. | Stock | 886 | $417.8K | <0.1% | History |
| NVSNovartis AG | ADR | 4,123 | $416.3K | <0.1% | History |
| SNNSmith & Nephew PLC | SPDN ADR NEW | 15,111 | $412.2K | <0.1% | History |
| CNCCentene Corp | Stock | 5,521 | $409.7K | <0.1% | History |
| HUMHumana Inc | Stock | 888 | $406.5K | <0.1% | History |
| FMSFresenius Medical Care AG | SPONSORED ADR | 19,490 | $406.0K | <0.1% | History |
| ENOVEnovis CORP | COM | 7,203 | $403.5K | <0.1% | History |
| ABBVAbbVie Inc. | Stock | 2,540 | $393.6K | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 7,711 | $383.5K | <0.1% | History |
| GSKGSK plc | ADR | 10,058 | $372.7K | <0.1% | History |
| GILDGilead Sciences, Inc. | Stock | 4,526 | $366.7K | <0.1% | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 25,630 | $365.7K | <0.1% | History |
| VTRSViatris Inc | Stock | 33,010 | $357.5K | <0.1% | History |
| MDTMedtronic plc | Stock | 4,188 | $345.0K | <0.1% | History |
| JNJJohnson & Johnson | Stock | 2,161 | $338.7K | <0.1% | History |
| IARTIntegra Lifesciences Holdings Corp | COM NEW | 7,261 | $316.2K | <0.1% | History |
| HCAHCA Healthcare, Inc. | COM | 1,160 | $314.0K | <0.1% | History |
| QDELQuidelOrtho Corp | COM | 4,257 | $313.7K | <0.1% | History |
| QGENQiagen N.V. | SHS NEW | 6,912 | $300.2K | <0.1% | History |
| UTHRUnited Therapeutics Corp | COM | 1,345 | $295.8K | <0.1% | History |
| XRAYDentsply Sirona Inc. | Stock | 8,228 | $292.8K | <0.1% | History |
| BIIBBiogen Inc. | COM | 1,096 | $283.6K | <0.1% | History |
| LHLabcorp Holdings Inc. | COM NEW | 1,218 | $276.8K | <0.1% | History |
| PDCOPatterson Companies, Inc. | COM | 9,264 | $263.6K | <0.1% | History |
| RVTYRevvity, Inc. | COM | 2,223 | $243.0K | <0.1% | History |
| Bayer AG072730302 | Common Stock | 25,475 | $235.1K | <0.1% | – |
| OGNOrganon & Co. | Stock | 12,716 | $183.4K | <0.1% | History |